Category Archives: Medicine Wellness Health

Medicine Wellness Health

Automated Suturing Devices Market to be Worth US$ 471 Mn by 2015

Global automated suturing devices market is estimated to account for US$ 471.0 Mn by the end of 2015, mainly driven by rising number of minimally invasive surgical procedures.

Automated Suturing Devices Market to be Worth US$ 471 Mn by 2015

Automated Suturing Devices Market

Future Market Insights (FMI), in its latest report titled, „Automated Suturing Devices Market: Global Industry Analysis and Opportunity Assessment 2015-2025“, forecasts the global automated suturing devices market revenue to expand at a CAGR of 5.3% during the forecast period (2015-2025). Global automated suturing devices market is estimated to account for US$ 471.0 Mn by the end of 2015, mainly driven by rising number of minimally invasive surgical procedures.

Use of automated suturing devices in minimal invasive surgeries, open surgical procedures and major trauma cases that require surgery is expected to drive the market during the forecast period. Preference for automated suturing devices over conventional suturing devices during laparoscopic surgeries is a key reason for growth. Further, the device is also preferred by procurement teams at hospitals as it labelled under „green products“, resulting in considerably less impact on the environment as compared to plastic single-use disposable suturing devices.Rise in geriatric population is a macro factor that“s driving demand for automated suturing devices.

High cost along with negative perception about certain automated suturing devices due tosome FDA-approved devices facing criticism regarding performance can impede the growth of the market.

Request Report Sample with Table of Contents: http://www.futuremarketinsights.com/reports/sample/rep-gb-579

The report analyses the global automated suturing devices market in terms of market value (US$ Mn) and market volume (units) by product type, region, end-user and application. The report also offers information regarding market dynamics, regulatory compliances, competitive landscape, current trends, market estimations and forecast.

Region-wise, North America is expected to account for maximum volume share in the global market by 2015and this is expected to double over the forecast period. Western Europe is the second-most lucrative market for automated suturing devices companies. The market revenue in this region is projected to witness a healthy CAGR of 5.6% during the forecast period.

Browse the full „Automated Suturing Devices Market: Global Industry Analysis and Opportunity Assessment 2015 – 2025“ market research report at http://www.futuremarketinsights.com/reports/automated-suturing-devices-market

Among product types, disposable automated suturing devices segment is expected to dominate the global automated suturing devices market,followed by the reusable automated suturing devices segment. Increasing prevalence of obesity is expected to boost overall demand for disposable automated suturing devices at a comparatively higher pace.

On the basis of application, automated suturing devices market is segmented into minimally invasive surgeries, open surgeries and trauma cases. Minimally invasive surgeries segment is expected to dominate the overall automated suturing devices market by the end of forecast period. The segment revenue is projected to register fastest growth rate over the forecast period. Open surgeries is projected to be the second fastest growing segment in terms of revenue. Increasing adoption of automated suturing devices among surgeons is fuelling growth of the minimally invasive surgeries segment.

Send An Enquiry: http://www.futuremarketinsights.com/askus/rep-gb-579

On the basis of end user, global automated suturing devices market has been segmented into hospitals, clinics and ambulatory surgical centers. Hospitals segment is expected to register fastest CAGR in terms of revenue over the forecast period.

Key players profiled in FMI“s market study include Medtronic Plc., Inc., Apollo Endosurgery, LSI Solutions, Inc., Boston Scientific, C. R. Bard, SuturTek Inc. and EndoEvolution, LLC.

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centres in the U.S. and India.

FMI“s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customised and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

Kontakt
Future Market Insights
Abhishek Budholiya
616 Corporate Way, Suite 2-9018, Valley Cottage NY
10989 New York
+442076928790
abhishek.b@futuremarketinsights.com
http://www.futuremarketinsights.com/

Medicine Wellness Health

Bone Growth Stimulators Market to Account for US$ 1,097.6 Mn by 2016

An external bone growth stimulator is prescribed for use for two to nine hours every day for a period of around three to nine months.

Bone Growth Stimulators Market to Account for US$ 1,097.6 Mn by 2016

Bone Growth Stimulators

According to the latest market report published by Future Market Insights titled, „Bone Growth Stimulators Market: Global Industry Analysis and Opportunity Assessment, 2015-2025“, the bone growth stimulators market is anticipated to expand at a CAGR of 9.5% during the forecast period.

Bone growth stimulators are used in cases of delay or failure of fracture healing as they enhance the bone healing process without the sensation of electrical shocks or currents or vibrations when worn by the user. An internal bone growth stimulator or invasive bone growth stimulator is implanted on the fusion site of the bone and it delivers small electrical currents. The internal bone growth stimulator is removed from the body after 6-12 months. External bone growth stimulator or non-invasive bone growth stimulators are externally worn portable devices and do not require surgical implantation. An external bone growth stimulator is prescribed for use for two to nine hours every day for a period of around three to nine months.

Economic factors such as improvement in service sector, increase in personal income, and increase in per capita healthcare expenditure are expected to drive market growth globally. Captivating product features, expanding application in the sports medicine industry, high disability cost payments, among others, are fuelling growth of the global bone growth stimulators market. However, various factors such as availability of alternative therapies, uncertainty about efficacy, device-related issues and competition from bone grafts restraint growth of the bone growth stimulators market.

Request Report Sample with Table of Contents: http://www.futuremarketinsights.com/reports/sample/rep-gb-828

By product, the global bone growth stimulators market is segmented into invasive bone growth stimulators, non-invasive bone growth stimulators and ultrasound bone growth stimulators. The non-invasive bone growth stimulators product segment-which comprises capacitive coupling devices, combined magnetic field devices and pulsed ultrasound magnetic field devices-accounts for the highest market share currently and is expected to remain the leading segment in terms of value during the forecast period. In terms of application segmentation, trauma injury and fractures segment is expected to expand at the highest CAGR in terms of value and volume over the forecast period as compared to other applications. Hospitals end user segment, though projected to account for the highest share in market, is expected to expand at an average CAGR in terms of value and volume over the forecast period. Orthopedic clinics and home care end user segments are expected to represent significant market attractiveness indices over the forecast period.

Browse the full „Bone Growth Stimulators Market: Global Industry Analysis and Opportunity Assessment, 2015-2025“ market research report at http://www.futuremarketinsights.com/reports/bone-growth-stimulators-market

By region, North America is expected to remain the market leader in the bone growth stimulators market mainly due to consumer awareness about chronic pain related to bone fracture and injury and subsequent disability costs. Western Europe is the second-largest contributor to the global market in terms of value and volume owing to availability of public health systems and subsidies coupled with reliance of patients on the Internet to research about new technologies, such as bone growth stimulators. MEA is projected to expand at a significant pace mainly due to large (particularly expatriate) population, improvements in life expectancy and decline in mortality rates, combined with increased budgetary spend on healthcare, resulting in a major shift and boost in growth of the bone growth stimulators market in the MEA countries. The MEA bone growth stimulators market is still untapped, so companies have substantial growth opportunities in this region.

Send An Enquiry: http://www.futuremarketinsights.com/askus/rep-gb-828

Key market players covered in this report are DJO LLC, Orthofix International N.V., Zimmer Biomet Holdings Inc., Elizur, Bioventus LLC., Ossatec Benelux BV, Verve Consulting Inc. and IGEA S.p.A. Major players in the bone growth stimulators market are focusing on enhancing their global and regional presence through strategic mergers & acquisitions and operational expansion.

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centres in the U.S. and India.

FMI“s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customised and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

Kontakt
Future Market Insights
Abhishek Budholiya
616 Corporate Way, Suite 2-9018, Valley Cottage NY
10989 New York
+442076928790
abhishek.b@futuremarketinsights.com
http://www.futuremarketinsights.com/

Medicine Wellness Health

Breast Pumps Market Will hit at a CAGR of 5% from 2016 to 2026

Breast pumps haven“t undergone the same level of innovation as other medical devices, prompting the „Make the Breast Pump Not Suck“ hackathon at MIT Media Lab in 2014.

Breast Pumps Market Will hit at a CAGR of 5% from 2016 to 2026

Breast Pumps Market

„Breast Pumps Market: Global Industry Analysis and Opportunity Assessment, 2016-2026“, a new report by research and consulting firm, Future Market Insights (FMI) forecasts the global breast pumps market to increase at 5% CAGR through 2026 and surpass US$ 2 Bn in revenues. The report offers 10-year forecast and analysis on the basis of product, technology, application, and region. Key companies profiled in the report include Koninklijke Philips N.V, Pigeon Corporation, Jarden Corporation, Goodbaby International Holdings Ltd., Medela Inc., Ameda Inc., Hygeia Medical Group II, Bailey Medical, Handi-Craft Company, Mayborn Group Limited, and Linco Baby Merchandise Works Co., Ltd.

Breast pumps haven“t undergone the same level of innovation as other medical devices, prompting the „Make the Breast Pump Not Suck“ hackathon at MIT Media Lab in 2014. The hackathon received massive media coverage, bringing daunting challenges associated with breast pumps to the limelight. While breast pumps have enabled women to maintain their milk production and provide nutritious feed to their babies in their absence, using the pumps has been a complicated affair. High cost, deafening loud motors, and difficulty in cleaning numerous parts has forced many women to wean.

Request Report Sample with Table of Contents: http://www.futuremarketinsights.com/reports/sample/rep-gb-967

The winners of M.I.T“s hackathon presented interesting, futuristic ideas that could change the breast pumps landscape for the better. Hands-free, discrete, and easy to clean – the winning products incorporated features that women have been yearning for a long time. Manufacturers looking to gain a competitive edge need to work on including these features in their offerings.

Global Breast Pumps Market: Challenges and Opportunities

Global demand for breast pumps will continue to grow, as the percentage of working moms increases, especially in developing countries. Breast pumps“ use as a life-saving device for infants who cannot feed directly from the breast is also expected to contribute to global demand.

Browse the full „Breast Pumps Market: Global Industry Analysis and Opportunity Assessment, 2016-2026“ market research report at http://www.futuremarketinsights.com/reports/breast-pumps-market

According to FMI“s report, double electric breast pumps are witnessing higher demand than single electric- and manual- breast pumps. Ease of use and faster expression of milk are the key factors driving demand for double electric breast pumps. Overall, demand for breast pumps is higher from individual consumer (s) vis-à-vis hospitals.

High Demand Expected in Emerging Economies

North America and Western Europe are the two largest markets for breast pumps globally, with the former accounting for nearly 35% revenue share of the market in 2015. Developing economies promise myriad growth opportunities to manufactures, as the breast pumps market in these region is still in its infancy. According to FMI“s report, the Asia Pacific excluding Japan (APEJ) breast pumps market is anticipated to witness a CAGR of 7.1% CAGR, whereas the Eastern Europe breast pumps market is expected to increase at 4.5% CAGR. Russia is the most lucrative market for breast pumps in Eastern Europe, and is projected to increase at 4.6% CAGR during the forecast period.

Send An Enquiry: http://www.futuremarketinsights.com/askus/rep-gb-967

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centres in the U.S. and India.

FMI“s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customised and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

Kontakt
Future Market Insights
Abhishek Budholiya
616 Corporate Way, Suite 2-9018, Valley Cottage NY
10989 New York
+442076928790
abhishek.b@futuremarketinsights.com
http://www.futuremarketinsights.com/

Medicine Wellness Health

Dental Imaging Equipment Market Revenue is expected to reach US$ 2.1 Bn in 2016

Lack of skilled professionals and lower lifespan of accessories used in such equipment are anticipated to restrain the global expansion and hamper the growth opportunities for the dental imaging equipment market.

Dental Imaging Equipment Market Revenue is expected to reach US$ 2.1 Bn in 2016

Dental Imaging Equipment Market

Increase in the number of cosmetic dental surgeries across the world is expected to supplement the demand for enhanced dental imaging equipment. Valued at US$ 2,088.2 Mn in 2015, the global market for dental imaging equipment is expected to surge at a y-o-y growth rate of 5.1% and reach US$ 2,194.7 Mn in 2016. The high prevalence of dental ailments, such as gingivitis, tooth decay, and dry mouth in Europe, North America and Asia Pacific will continue to be an influencing factor for the growth of the dental imaging equipment market. Increasing awareness of dental hygiene is also a key driver fuelling the demand for advanced dental imaging apparatus.

Lack of skilled professionals and lower lifespan of accessories used in such equipment are anticipated to restrain the global expansion and hamper the growth opportunities for the dental imaging equipment market.

Request Report Sample with Table of Contents: http://www.futuremarketinsights.com/reports/sample/rep-gb-861

By product-type, extraoral X-ray system will continue to dominate the market; however, the cone-beam computed tomography (CBCT) imaging product is likely to register rapid growth in terms of value and reach US$ 395.7 Mn in 2016.

By end-use, dental clinics and ambulatory surgical centres will witness higher adoption of dental imaging equipment in 2016 and beyond. In terms of market revenue, the independent dental clinics are expected to grow exponentially and contribute US$ 1,480.5 Mn in the global market. Forensic laboratories and hospitals are also anticipated to be prominent end-users of dental imaging equipment, owing to the pathological and surgical use of dental imaging devices.

Browse Full Report: http://www.futuremarketinsights.com/reports/dental-imaging-equipment-market

Owing to the high adoption of CBCT imaging products in the U.S., North America will continue to remain the largest market for dental imaging equipment globally. Europe and APEJ regions will jointly account for over 40% revenue share in 2016.

The key players in the global dental imaging equipment market include Acteon Group, Planmeca Oy, Danaher Corporation, Carestream Health, VAtech Co. Ltd., and Dentsply Sirona, among others. Danaher Corporation is expected to be the utmost dominating company in the global market, owing to the company“s flagship product range of advanced CBCT equipment.

Send An Enquiry: http://www.futuremarketinsights.com/askus/rep-gb-861

Long-term Outlook: The global dental imaging equipment market is projected to expand at a moderate CAGR of 6.8% during the forecast period 2016-2024. By the end of the forecast period, the global market for dental imaging equipment is estimated to reach market value of US$ 3,712.7 Mn.

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centres in the U.S. and India.

FMI“s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customised and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

Kontakt
Future Market Insights
Abhishek Budholiya
616 Corporate Way, Suite 2-9018, Valley Cottage NY
10989 New York
+442076928790
abhishek.b@futuremarketinsights.com
http://www.futuremarketinsights.com/

Medicine Wellness Health

Regenerative Medicine Market Will hit at a CAGR of 11.1% from 2015 to 2019

Europe is the second largest market for regenerative medicine, with the region“s high geriatric population fuelling adoption at a robust pace.

Regenerative Medicine Market Will hit at a CAGR of 11.1% from 2015 to 2019

Regenerative Medicine Market

The global regenerative medicine (bone and joint) market was valued at US$ 4,254.0 Mn in 2015, and is expected to grow at a year-over-year rate of 13.0% to reach US$ 4,808.9 Mn in 2016. In 2015, North America accounted for the largest revenue share of global regenerative medicine (bone & joints) market, representing a market value of US$ 2,039.8 Mn. Owing to increasing demand for bone and joint reconstructive surgeries and encouraging government initiatives, North America is expected to remain the largest market for regenerative medicine (bone and joint) in 2016. Europe is the second largest market for regenerative medicine, with the region“s high geriatric population fuelling adoption at a robust pace.

By technology, biomaterials segment accounts for the highest market share globally, owing to favourable reimbursement policies and strong demand for biomaterials. Apart from biomaterials, tissue engineering is the other segment which is quickly gaining traction among end-users, and is projected to witness the highest year-over-year growth among all the technology segments.

Request Report Sample with Table of Contents: http://www.futuremarketinsights.com/reports/sample/rep-gb-1326

On the basis of application, bone graft substitute holds the highest share of the market in terms of value owing to a robust demand of bone graft substitute in orthopaedic treatments. However, complications associated with bone graft substitute can pose challenges to adoption in 2016 and beyond.

While North America and Europe are key to the growth of the regenerative medicine market, rising awareness among healthcare professionals and patients in developing countries of Asia Pacific is expected to open up new opportunities for stakeholders. Favourable government initiatives in growing Asian economies such as China and India has paved the way for regenerative medicine market in the region. Moreover, adoption in developed countries of APAC, such as Japan and South Korea is also fuelling the growth of the market.

Browse Full Report: http://www.futuremarketinsights.com/reports/regenerative-medicine-market

Key participants in the global regenerative medicine market are: Medtronic, Inc. (INFUSE Bone Graft), DePuy Synthes, Inc. (HEALOS Bone Graft), Orthofix, Inc. (Trinity Evolution), NuVasive, Inc. (Osteocel Plus) and Zimmer Holdings, Inc. (CopiOs Bone Void Filler). The key strategy of these players is to expand globally through distribution agreements, mergers and acquisitions, public-private partnerships and new product development.

Long-term Outlook: The global regenerative medicine market (bone and joints) is anticipated to increase at a CAGR of 11.1% during the forecast period from 2015 to 2019. North America will remain the largest market throughout the forecast period, whereas Bone Graft Substitutes will continue to hold the largest share in terms of application.

Send An Enquiry: http://www.futuremarketinsights.com/askus/rep-gb-1326

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centres in the U.S. and India.

FMI“s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customised and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

Kontakt
Future Market Insights
Abhishek Budholiya
616 Corporate Way, Suite 2-9018, Valley Cottage NY
10989 New York
+442076928790
abhishek.b@futuremarketinsights.com
http://www.futuremarketinsights.com/

Medicine Wellness Health

Coronary Stents Market Revenue to Register a CAGR of 6.6% by 2026

The global coronary stents market is expected to represent incremental opportunity of US$ 5,318.7 Mn between 2016 and 2026.

Coronary Stents Market Revenue to Register a CAGR of 6.6% by 2026

Coronary Stents Market

Future Market Insights provides an in-depth analysis of the global coronary stents market in a new report titled „Coronary Stents Market: Global Industry Analysis and Opportunity Assessment, 2016-2026“. Coronary stents is a billion dollars industry that occupies a significant market share in the cardiovascular market. In terms of revenue, the global coronary stents market is estimated to reach a market valuation of US$ 6,002.9 Mn by 2016 end and is expected to register a CAGR of 6.6% during the forecast period. The global coronary stents market is expected to represent incremental opportunity of US$ 5,318.7 Mn between 2016 and 2026.

According to Future Market Insights, factors such as an increase in the prevalence of coronary artery disease, obesity, and minimal invasive procedures; and an increasing preference for advanced stenting procedures by cardiologists are some of the factors fuelling the growth of the global coronary stents market. Economic factors such as an increase in awareness campaigns about cardiovascular diseases conducted by government bodies, rapid progress in medical technology, and extended reimbursement support are also expected to boost the growth of the global coronary stents market over the forecast period.

Request Report Sample with Table of Contents: http://www.futuremarketinsights.com/reports/sample/rep-gb-1993

Segmentation highlights

The global coronary stents market is segmented on the basis of Product Type (Drug Eluting Stent, Bare Metal Stent, Bioresorbable Vascular Stent); Raw Material (Cobalt Chromium, Stainless Steel, Platinum-Chromium, Nickel-Titanium, Polymer); and End Use (Hospitals, Ambulatory Surgical Centres, Cardiac Catheterisation Laboratories).

The Drug Eluting Stent product type segment is estimated to be valued at US$ 8,750.2 Mn by 2026. The Bioresorbable Vascular Stent segment is estimated to account for 11.0% revenue share by 2016 end

Browse Full Report: http://www.futuremarketinsights.com/reports/coronary-stents-market

The Polymer raw material segment is estimated to account for the highest market share of 29.2% by the end of 2016. The Cobalt Chromium segment is expected to register a CAGR of 5.6% during the forecast period

The Hospitals end use segment is anticipated to account for 70.9% value share of the global coronary stents market by the end of 2016. The Cardiac Catheterisation Laboratories segment is estimated to be valued at US$ 2,526.8 Mn by the end of 2026, registering a CAGR of 8.0% over the forecast period

Regional projections

The global coronary stents market is segmented on the basis of region into North America, Latin America, Western Europe, Eastern Europe, APEJ, MEA, and Japan. The APEJ market is estimated to be valued at US$ 4,165.2 Mn by 2026, exhibiting a CAGR of 8% during the forecast period. The North America coronary stents market is expected to dominate the global coronary stents market in terms of revenue by 2016 end and is likely to retain its dominance throughout the forecast period. The coronary stents market in North America is estimated to account for 29.2% market share of the global coronary stents market by 2016 end. The North America region is likely to be the second most attractive market with an attractiveness index of 2.5 during the forecast period. The markets in North America, Western Europe, and APEJ represent the highest growth opportunities in the global coronary stents market owing to a large patient population and an increasing demand for coronary stents in these regions.

Send An Enquiry: http://www.futuremarketinsights.com/askus/rep-gb-1993

Vendor insights

The global coronary stents market report profiles some of the top companies operating in the market. Leading market players featured in the report include Terumo Corporation, Boston Scientific Corporation, Medtronic, Vascular Concepts, B. Braun Melsungen AG, Biotronik SE & Co. KG, Abbott Laboratories, Biosensors International Group, Ltd., Hexacath, and Stentys SA. Key market players are focussing on increasing their footprints in emerging markets such as Asia Pacific and are expanding their manufacturing facilities and distribution network to gain a larger share of the global coronary stents market.

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centres in the U.S. and India.

FMI“s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customised and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

Kontakt
Future Market Insights
Abhishek Budholiya
616 Corporate Way, Suite 2-9018, Valley Cottage NY
10989 New York
+442076928790
abhishek.b@futuremarketinsights.com
http://www.futuremarketinsights.com/

Medicine Wellness Health

Positron Emission Tomography (PET) Scanners Market Revenue is expected to reach US$ 1,480.2 Mn by 2026

In terms of revenue, the global Positron Emission Tomography (PET) scanners market is projected to register a healthy CAGR of 4.7% over the forecast period.

Positron Emission Tomography (PET) Scanners Market Revenue is expected to reach US$ 1,480.2 Mn by 2026

Positron Emission Tomography Scanners Market

Future Market Insights delivers key insights on the global Positron Emission Tomography scanners market in a new report titled, „Positron Emission Tomography (PET) Scanners Market: Global Industry Analysis and Opportunity Assessment, 2016-2026“. In terms of revenue, the global Positron Emission Tomography (PET) scanners market is projected to register a healthy CAGR of 4.7% over the forecast period.

According to Future Market Insights, growing occurrences of chronic disorders and increasing penetration of PET machines is expected to drive overall growth of the global Positron Emission Tomography (PET) scanners market during the forecast period. Rising demand for effective diagnostic techniques across the globe and expanded applications for PET in the field of oncology are further expected to boost the growth of the global Positron Emission Tomography (PET) scanners market between 2016 and 2026. However, a short half-life and low supply of radiopharmaceuticals is likely to restrict market growth over the forecast period.

Request Report Sample with Table of Contents: http://www.futuremarketinsights.com/reports/sample/rep-gb-1333

„A key trend in the global Positron Emission Tomography (PET) scanners market is the development of dual modality PET/CT and PET/MRI machines leading to better diagnostic sensitivity and specificity at each stage of disease prognosis. The entry of new radiopharmaceuticals has enhanced the diagnostic value of diseases treatment resulting in greater dependency on PET scanning procedures. These trends are likely to govern the global Positron Emission Tomography (PET) scanners market in the coming years.“ – Analyst – Healthcare, Pharmaceuticals & Medical Devices, Future Market Insights

Segmentation highlights

The global Positron Emission Tomography (PET) scanners market has been segmented by Product Type (Full Ring PET Scanners, Partial Ring PET Scanners); by Application (Oncology, Cardiology, Neurology, Others); by Detector Type (Bismuth Germanium Oxide (BGO), Lutetium Oxyorthosilicate (LSO), Gadolinium Oxyorthosilicate (GSO), Lutetium Fine Silicate (LFS), Lutetium Yttrium Orthosilicate); and by End User (Hospitals, Diagnostic Centres, PET Centres, Research Institutes);

The Full Ring PET Scanners product type segment was valued at US$ 759.3 Mn in 2015 and is expected to register 4.8% CAGR over the forecast period. The Partial Ring PET Scanners product type segment was valued at US$ 143.8 Mn in 2015 and is expected to increase to US$ 212.2 Mn by the end of 2026

The Oncology application segment is estimated to account for 86.6% market share by 2016 while the Cardiology application segment is estimated to account for 5.0% market share by 2016 end. Both these segments are expected to be the most lucrative segments in the global Positron Emission Tomography (PET) scanners market during the forecast period

Browse Full Report: http://www.futuremarketinsights.com/reports/positron-emission-tomography-scanners-market

The Lutetium Oxyorthosilicate (LSO) detector type segment was valued at US$ 322.7 Mn in 2015 and is expected to witness a CAGR of 4.3% over the forecast period to reach US$ 596.5 Mn by 2026 end. The Bismuth Germanium Oxide (BGO) detector type segment was valued at US$ 266.7 Mn in 2015 and is expected to increase to US$ 400.5 Mn by the end of 2026

The Hospitals end user segment is estimated to hold 35.7% market share by 2016 end while the Diagnostic Centres end user segment is estimated to account for 33.0% market share by 2016 end

Regional market projections

The global Positron Emission Tomography (PET) scanners market has been segmented into the seven key regions of North America, Latin America, Western Europe, Eastern Europe, APEJ, MEA, and Japan. North America dominated the global Positron Emission Tomography (PET) scanners market in 2015 and is likely to continue its dominance throughout the forecast period. North America is expected to reach a market valuation of US$ 631.9 Mn by 2026 end, witnessing a CAGR of 4.8% over the forecast period. The APEJ Positron Emission Tomography (PET) scanners market is estimated to be valued at US$ 132.9 Mn by 2016 end and is expected to register a CAGR of 5.1% over the forecast period.

Send An Enquiry: http://www.futuremarketinsights.com/askus/rep-gb-1333

Vendor insights

General Electric Co., Toshiba Corporation, Koninklijke Philips N.V., Siemens AG, Hitachi, Ltd., Positron Corporation, Mediso Ltd., and Yangzhou Kindsway Biotech Co. Ltd. are some of the leading players operating in the global Positron Emission Tomography (PET) scanners market. Major players in the global Positron Emission Tomography (PET) scanners market are focussing on enhancing their global and regional presence through introduction of novel products and strategic operational expansion. The report discusses individual strategies followed by these companies in terms of enhancing product designing, creating new manufacturing facilities, market consolidation, and advanced R&D initiatives.

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centres in the U.S. and India.

FMI“s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customised and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

Kontakt
Future Market Insights
Abhishek Budholiya
616 Corporate Way, Suite 2-9018, Valley Cottage NY
10989 New York
+442076928790
abhishek.b@futuremarketinsights.com
http://www.futuremarketinsights.com/

Medicine Wellness Health

Balloon Catheter Market Revenue is expected to reach US$ 4,191.7 Mn by 2026

Future Market Insights provides in-depth analysis and insights into the global balloon catheter market and studies the factors and restraints impacting the market during the forecast period.

Balloon Catheter Market Revenue is expected to reach US$ 4,191.7 Mn by 2026

Balloon Catheter Market

Balloon catheter is a billion dollars market accounting for a substantial proportion of healthcare expenditure worldwide. The global balloon catheter market is expected to reach US$ 2,887.4 Mn in 2016 and is projected to register a CAGR of 3.8% during the period 2016-2026. The market is anticipated to reach 16,587 thousand units in terms of volume by the end of 2026. In a new report titled „Balloon Catheter Market: Global Industry Analysis and Opportunity Assessment, 2016-2026“, Future Market Insights provides in-depth analysis and insights into the global balloon catheter market and studies the factors and restraints impacting the market during the forecast period.

According to Future Market Insights, a rising prevalence of cardiac diseases leading to interventional cardiology procedures and an increasing geriatric population prone to cardiac arrest is expected to fuel the growth of the global balloon catheter market over the forecast period. „Economic factors such as growing healthcare expenditure, increasing disposable income per capita, rising government support in developed economies, and favourable reimbursement policies are expected to boost the growth of the global balloon catheter market over the forecast period.“ Analyst, Future Market Insights.

Request Report Sample with Table of Contents: http://www.futuremarketinsights.com/reports/sample/rep-gb-1916

However, a high cost of coronary angioplasty and stenting treatment and risk of infection and artery collapse associated with balloon catheterisation is likely to hinder market growth over the forecast period.

The global balloon catheter market is segmented on the basis of product type (Normal Balloon Catheter, Cutting Balloon Catheter, Scoring Balloon Catheter, Drug Eluting Balloon Catheter, Stent Graft Balloon Catheter); disease indication (Coronary Artery Disease, Peripheral Vascular Disease); raw material (Polyurethane, Nylon, Others); and end user (Public Hospitals & Private Hospitals, Ambulatory Surgical Centres, Cardiac Catheterisation Laboratories).

Segmentation highlights

The Drug eluting product type balloon catheter segment is expected to expand at a CAGR of 20.0% in terms of value over the forecast period while the Stent graft balloon catheter segment is estimated to account for 33.9% revenue share by 2016 end

The Polyurethane raw material segment is expected to expand at a CAGR of 4.6% while the Nylon segment is expected to expand at a CAGR of 3.8% in terms of value over the forecast period

Browse Full Report@ http://www.futuremarketinsights.com/reports/balloon-catheter-market

The Coronary artery disease indication segment is projected to dominate the global balloon catheter market in terms of value; the Peripheral vascular disease indication segment is expected to expand at a CAGR of 3.1% in terms of value over the forecast period

Among end users, the Ambulatory surgical centres segment is expected to expand at a CAGR of 2.7% in terms of value over the forecast period while the Cardiac catheterisation laboratories segment is estimated to account for 19.8% revenue share by 2016 end

Regional forecast

The global balloon catheter market is segmented into seven key regions – North America, Latin America, Western Europe, Eastern Europe, APEJ, Japan, and MEA. Sales of balloon catheters have remained quite healthy in the U.S. market in recent years, making North America the most lucrative market globally. Revenue from the North America market is anticipated to expand at a CAGR of 3.5% from 2016 to 2026 to reach US$ 1,312.2 Mn by 2026. In addition to North America, balloon catheters sales are also growing steadily in Japan, MEA, and APEJ. Revenues in APEJ are anticipated to grow by 4.2% whereas MEA is expected to increase at 3.4% over the forecast period.

Send An Enquiry@ http://www.futuremarketinsights.com/askus/rep-gb-1916

Vendor insights

Boston Scientific Inc., Medtronic, Terumo Corporation, MicroPort Scientific Corporation, B. Braun Melsungen AG, Jotech GmbH, QX Medical LLC, Meril Life Pvt. Ltd., Hexacath, Abbott Laboratories, Tokai Medical Products Inc., Biosensors International Ltd., Cook Medical Inc., Cardionovum GmbH, Cordis Corporation, and Biotronik Inc. are the leading companies operating in the global balloon catheter market. Major market players are adopting strategies such as mergers and acquisitions to maintain their market share.

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centres in the U.S. and India.

FMI“s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customised and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

Kontakt
Future Market Insights
Abhishek Budholiya
616 Corporate Way, Suite 2-9018, Valley Cottage NY
10989 New York
+442076928790
abhishek.b@futuremarketinsights.com
http://www.futuremarketinsights.com/

Medicine Wellness Health

Hypercalcemia Treatment Market to Reach US$ 9.64 Bn in 2017

Availability of drug therapy alternatives over surgeries and favourable reimbursement policies are key factors expected to fuel global market growth.

Hypercalcemia Treatment Market to Reach US$ 9.64 Bn in 2017

Hypercalcemia Treatment Market

Global hypercalcemia treatment market revenues are anticipated to reach US$ 9.64 Bn in 2017, up from US$ 7.86 Bn in 2015. Increasing prevalence of hyperparathyroidism-related hypercalcemia and rising incidence of multiple myeloma are major factors expected to fuel growth of the global hypercalcemia treatment market over the forecast period. Availability of drug therapy alternatives over surgeries and favourable reimbursement policies are key factors expected to fuel global market growth.

Hospitals remain the largest distribution channel in the hypercalcemia market in terms of revenue contribution, accounting for around 39% share to the global market in 2015. Rapid diagnosis and easy availability of hypercalcemia drugs are key factors attributed to increasing revenue from the hospitals end user segment, and hospitals are expected to continue to remain the largest distribution channel for hypercalcemia treatment in the long-term.

Request Report Sample with Table of Contents: http://www.futuremarketinsights.com/reports/sample/rep-gb-1320

Bisphosphonates product type segment is estimated to continue to account for relatively higher revenue share to the global market, at over 67% in 2016 end. U.S. FDA approval of denosumab (Xgeva) for treating hypercalcemia of malignancy refractory in 2014 has boosted the use of biophosphonates. Glucocorticoids and calcimimetics segments are also anticipated to witness steady revenue growth in the near future.

North America and Western Europe are among the leading markets for hypercalcemia treatment, with the former accounting for revenue share of 46% in 2015. The North America hypercalcemia treatment market is anticipated to be valued at US$ 4.39 Bn in 2017, up from US$ 3.61 Bn in 2015. The market in North America is dominated by the U.S. Higher prevalence of malignancy-related hypercalcemia among cancer patients in North America will continue to influence market growth in the near future.

Browse Full Report@ http://www.futuremarketinsights.com/reports/hypercalcemia-treatment-market

Amgen Inc., Novartis AG, and Teva Pharmaceuticals Industries Ltd., Pfizer Inc., and F.Hoffmann-La Roche Ltd. are among the leading players in the global hypercalcemia market. The U.S. remains a lucrative market for majority of leading players; foraying into emerging markets of Asia and Africa is a key focus area for global players.

Long-term Outlook: The global hypercalcemia market is anticipated to register a CAGR of 11.2% in terms of revenue during forecast period 2016-2026, and reach a value of US$ 25.23 Bn by 2026.

Send An Enquiry@ http://www.futuremarketinsights.com/askus/rep-gb-1320

Related Reports:

Arthroscopy Procedures and Products Market: http://www.futuremarketinsights.com/reports/arthroscopy-procedures-products-market

Viscosupplementation Market: http://www.futuremarketinsights.com/reports/europe-viscosupplementation-market

Light Therapy Market: http://www.futuremarketinsights.com/reports/light-therapy-market

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centres in the U.S. and India.

FMI“s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customised and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

Kontakt
Future Market Insights
Abhishek Budholiya
616 Corporate Way, Suite 2-9018, Valley Cottage NY
10989 New York
+442076928790
abhishek.b@futuremarketinsights.com
http://www.futuremarketinsights.com/

Medicine Wellness Health

Special Purpose Needles Market to be a US$ 17.26 Bn by 2026

Future Market Insights delivers key insights on the factors and trends impacting the global special purpose needles market over a 10-year forecast period (2016-2026).

Special Purpose Needles Market to be a US$ 17.26 Bn by 2026

Special Purpose Needles Market

The global special purpose needles market is projected to be valued at US$ 17,261.5 million by the end of 2026, registering a CAGR of 7.4% during the forecast period (2016-2026). In a new report titled „Special Purpose Needles Market: Global Industry Analysis and Opportunity Assessment, 2016-2026“, Future Market Insights delivers key insights on the factors and trends impacting the global special purpose needles market over a 10-year forecast period (2016-2026).

The market for special purpose needles is witnessing steady growth across the globe owing to an increasing geriatric population. According to analysts at Future Market Insights, „Increasing prevalence of diabetes and infectious diseases and increasing incidence of cancer and spine disorders across the globe are the primary factors driving the growth of the global special purpose needles market.“ Availability of better reimbursement options for some types of special purpose needles in developed economies is likely to propel demand for special purpose needles over the forecast period. A key trend witnessed in the global special purpose needles market is the development of advanced techniques in the production of special purpose needles to facilitate enhanced patient safety and comfort. However, rise in awareness on needle free injections and risks associated with injections are major factors expected to hamper the overall growth of the special purpose needles market over the forecast period.

Request Report Sample with Table of Contents: http://www.futuremarketinsights.com/reports/sample/rep-gb-583

The global special purpose needles market can be segmented on the basis of product type (Fine Aspirating Needles, Biopsy Needles, Hypodermic Needles, Pen Needles, Suture Needles, IV Catheter Needles, Implantation Needles, Dental Needles, Ophthalmic Needles, Blood Collection Needles, Spinal Anaesthesia Needles, Epidural Needles, AV Fistula Needles, Cannula Needles); application (Sample Collection, Drug Delivery); and distribution channel (Hospital Pharmacies, Private Clinics, Retail Pharmacies and Drug Stores, E-Commerce).

Segmentation highlights

The Pen Needles product type segment is expected to gain popularity over the forecast period, driven by increasing global adoption of small sized needles for insulin injections. The Pen Needles product type segment is estimated to reach a valuation of US$ 644.3 Mn by the end of 2016, registering a CAGR of 9.1% over the forecast period.

Send An Enquiry@ http://www.futuremarketinsights.com/askus/rep-gb-583

The Sample Collection application segment is estimated to register a CAGR of 7.7% while the Drug Delivery application segment is expected to register a CAGR of 7.1% during the forecast period.

Demand for special purpose needles over the forecast period is expected to be the highest in the Hospital Pharmacies distribution channel segment, which is expected to register a CAGR of 8.5% in terms of value.

Regional forecast

The North America market has been estimated to dominate the special purpose needles market while the market in APEJ is expected to be the fastest growing in terms of revenue growth. The markets in North America, Western Europe, and APEJ are estimated to collectively hold 74.7% market share of the global special purpose needles market in 2016.

Browse Full Report@ http://www.futuremarketinsights.com/reports/special-purpose-needles-market

Vendor insights

Medtronic, B. Braun Melsungen AG, Becton, Dickinson and Company, Terumo Corporation, Smiths Medical, Boston Scientific Corporation, Novo Nordisk A/S, Argon Medical Devices, Inc., Stryker Corporation, NIPRO Medical Corporation, Cook Medical, and SERAG-WIESSNER GmbH & Co. are some of the major companies operating in the global special purpose needles market. These companies are adopting innovative strategies to bring in improvements to their product design and are initiating advanced R&D activities and market consolidation to strengthen market foothold and expand customer base.

Related Reports:

Respiratory Inhaler Devices Market: http://www.futuremarketinsights.com/reports/respiratory-inhaler-devices-market

U.S Compounding Pharmacies Market: http://www.futuremarketinsights.com/reports/us-compounding-pharmacies-market

Vital Signs Monitoring Devices Market: http://www.futuremarketinsights.com/reports/vital-signs-monitoring-devices-market

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centres in the U.S. and India.

FMI“s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customised and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

Kontakt
Future Market Insights
Abhishek Budholiya
616 Corporate Way, Suite 2-9018, Valley Cottage NY
10989 New York
+442076928790
abhishek.b@futuremarketinsights.com
http://www.futuremarketinsights.com/